PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
4.70%
Revenue growth under 50% of MCHP's 10.82%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
171.79%
Gross profit growth above 1.5x MCHP's 15.09%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
-1233.33%
Negative EBIT growth while MCHP is at 140.04%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1233.33%
Negative operating income growth while MCHP is at 132.00%. Joel Greenblatt would press for urgent turnaround measures.
-700.00%
Negative net income growth while MCHP stands at 87.97%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-445.24%
Negative EPS growth while MCHP is at 70.34%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-445.24%
Negative diluted EPS growth while MCHP is at 70.34%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.04%
Share reduction more than 1.5x MCHP's 0.33%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.04%
Diluted share reduction more than 1.5x MCHP's 0.33%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
-0.04%
Dividend reduction while MCHP stands at 10.17%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
3256.25%
OCF growth above 1.5x MCHP's 33.85%. David Dodd would confirm a clear edge in underlying cash generation.
223.77%
FCF growth above 1.5x MCHP's 34.43%. David Dodd would verify if the firm’s strategic investments yield superior returns.
34.49%
10Y revenue/share CAGR at 50-75% of MCHP's 51.09%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
34.49%
Positive 5Y CAGR while MCHP is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
10.19%
Positive 3Y CAGR while MCHP is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-25.93%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-25.93%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-169.92%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
52.64%
Below 50% of MCHP's 145.07%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
52.64%
5Y equity/share CAGR above 1.5x MCHP's 14.52%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
31.37%
3Y equity/share CAGR above 1.5x MCHP's 17.81%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-15.63%
Cut dividends over 10 years while MCHP stands at 180.63%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-15.63%
Negative 5Y dividend/share CAGR while MCHP stands at 175.02%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
56.25%
3Y dividend/share CAGR at 50-75% of MCHP's 81.65%. Martin Whitman might see a weaker short-term approach to distributing cash.
-19.11%
Firm’s AR is declining while MCHP shows 10.99%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-1.00%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.45%
Positive asset growth while MCHP is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-3.32%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-4.34%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
10.16%
SG&A growth well above MCHP's 4.80%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.